Telemus Capital’s Encompass Health EHC Stock Holding History

Telemus Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,771	Closed	-$234K	–	431
2018 Q3	$234K	Buy	+3,771	New	+$229K	0.02%	401

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Telemus Capital's EHC Position: Q4 2018 in Review

Telemus Capital sold out of Encompass Health (EHC) in Q4 2018, closing a stake of 3,771 shares — an estimated $234K sold.

Telemus Capital first reported a position in EHC in Q3 2018 and held it in 1 quarter. The position peaked at $234K in Q3 2018. 447 funds tracked by Wall St. Rank hold EHC as of Q4 2018.

Telemus Capital reported no remaining Encompass Health position as of Q4 2018 after selling out during the quarter.
Telemus Capital sold 3,771 Encompass Health shares in Q4 2018, an estimated $234K.
Telemus Capital first reported a position in Encompass Health in Q3 2018 and held it in 1 quarter.
Telemus Capital's Encompass Health position peaked at $234K in Q3 2018.
447 funds tracked by Wall St. Rank held Encompass Health as of Q4 2018.

Based on Telemus Capital's 13F filing for Q4 2018, filed 6 Feb 2019.